Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

IBM, University of Alberta develop AI capable of predicting schizophrenia

Researchers at IBM and the University of Alberta have developed artificial intelligence (AI) algorithms capable of predicting schizophrenia with 74 percent accuracy.

Healthcare CEOs have made more since ACA became law

An analysis from Axios found CEOs of 70 of the largest healthcare organizations have seen their wages grow well above most Americans since the Affordable Care Act (ACA) was signed into law in 2010, but without incentives to control healthcare spending.

Competition for pediatric medical devices offers $50,000 in prizes

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) has announced a competition to develop new technology for pediatric care. The competition will award up to six prizes of $50,000 for innovative medical devices.

Thumbnail

CBO: ‘Skinny’ repeal of ACA would increase uninsured by 16M

The Senate’s ongoing debate of plans to repeal and/or replace the Affordable Care Act (ACA) has resulted in two separate Republicans plans being voted down. One hope for the party is to pass a so-called “skinny repeal” which eliminates the individual and employer mandates along with a medical device tax, but that approach would have an immediate impact on insurance coverage and premiums.

Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.

Roxwood Medical Inc., a leading provider of advanced cardiovascular specialty catheters, today announced it has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the United States.

Thumbnail

ACA ‘repeal-and-delay’ bill fails in Senate as industry worries about ‘skinny repeal’

As part of the Senate’s flurry of action on proposals to repeal and/or replace the Affordable Care Act, Republicans brought up the same bill to get rid much of the law, without a replacement ready, which had passed through Congress in 2015. This time, it failed, with seven Republicans and all Democrats voting against it.

Thumbnail

10 steps to improving patient care with technology

Technology has become integral to providing high quality care, yet many healthcare organizations struggle with utilizing their technology in the most effective way. A recent list created by SCI Solutions, providers of patient care management technology, featured 10 checkpoints of success to help organizations improve care.

The future of healthcare is the future of AI

Artificial intelligence (AI) will play a central part in the future of healthcare technology, according to a recent report from Kleiner Perkins Caufield & Byers, a venture capital firm. With the digital revolution approaching, the survey team aimed to identify what healthcare AI will look like in the near future.

Displaying 4401 - 4408 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup